证券代码：000615 证券简称：*ST美谷 公告编号：2025-083 奥园美谷科技股份有限公司 关于股票交易异常波动的公告 3、敬请广大投资者关注本公告风险提示内容，注意投资风险。 一、股票交易异常波动情况 奥园美谷科技股份有限公司（以下简称"公司"）股票（证券简称：*ST 美 谷，证券代码：000615）于 2025 年 10 月 13 日和 10 月 14 日连续两个交易日收 盘价格涨幅偏离值累计超过 12%，根据《深圳证券交易所交易规则》的有关规定， 属于股票交易异常波动的情况。 二、公司关注、核实情况说明 1、公司前期披露的信息不存在需要补充、更正之处。 2、公司未发现近期公共媒体报道了可能或已经对本公司股票交易价格产生 较大影响的未公开重大信息。 3、目前，除控股子公司湖北金环绿色纤维有限公司仍处于停产状态外，公 司其他子公司经营业务活动正常，内外部经营环境未发生重大变化。 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有 虚假记载、误导性陈述或重大遗漏。 特别风险提示： 1、截至本公告披露日，公司已进入预重整程序，公司尚未收到法院关于受 理重整申请的相关法律文书，申请人的重整申请 ...

Core Viewpoint - The company announced that its stock experienced an abnormal fluctuation, with a cumulative increase of over 12% in closing prices over two consecutive trading days on October 13 and 14, 2025 [1] Summary by Relevant Sections - **Stock Performance** - The stock price of the company rose cumulatively by over 12% during the specified trading days, indicating significant market activity [1] - **Disclosure and Information Verification** - The company confirmed that there is no need to supplement or correct previously disclosed information, and no undisclosed significant information affecting the stock price has been found recently [1] - **Operational Status** - Other subsidiaries of the company are operating normally, and there have been no significant changes in the internal or external environment [1] - **Insider Trading Activity** - The controlling shareholder and executives did not engage in buying or selling the company's stock during the period of abnormal fluctuation [1] - **Restructuring Status** - The company is currently in a pre-restructuring phase, but there is uncertainty regarding whether it will enter the restructuring process [1]

Market Overview - The medical beauty sector experienced a decline of 0.33% on October 14, with Huaxi Biological leading the drop [1] - The Shanghai Composite Index closed at 3865.23, down 0.62%, while the Shenzhen Component Index closed at 12895.11, down 2.54% [1] Individual Stock Performance - Jinbo Biological (code: 920982) closed at 276.60, up 5.58% with a trading volume of 17,000 shares [1] - *ST Meigu (code: 000615) closed at 3.63, up 4.61% with a trading volume of 326,000 shares [1] - Aimeike (code: 300896) closed at 175.49, down 0.10% with a trading volume of 24,200 shares [1] - Huaxi Biological (code: 688363) closed at 54.02, down 1.15% with a trading volume of 33,100 shares [1] Capital Flow Analysis - The medical beauty sector saw a net inflow of 7.7391 million yuan from main funds, while retail funds experienced a net inflow of 1.0341 million yuan [1] - Speculative funds had a net outflow of 8.7732 million yuan [1] Detailed Capital Flow for Individual Stocks - Aimeike had a net outflow of 9.3340 million yuan, down 2.20% [2] - *ST Meigu experienced a net inflow of 1.1847 million yuan, up 1.03% [2] - Huaxi Biological had a significant net outflow of 10.6702 million yuan, down 5.90% [2]

Group 1 - The medical beauty sector experienced a decline of 1.92% on October 13, with Ai Meike leading the drop [1] - The Shanghai Composite Index closed at 3889.5, down 0.19%, while the Shenzhen Component Index closed at 13231.47, down 0.93% [1] - Major stocks in the medical beauty sector showed mixed performance, with *ST Meigu rising by 5.15% to a closing price of 3.47, while Ai Meike fell by 2.32% to 175.66 [1] Group 2 - The net outflow of main funds in the medical beauty sector was 75.6993 million yuan, while retail investors saw a net inflow of 48.3038 million yuan [1] - Specific fund flows for major stocks indicated that Ai Meike had a net outflow of 51.1050 million yuan, representing a decrease of 10.15% [2] - Huaxi Biological and *ST Meigu also experienced significant net outflows of 15.8278 million yuan and 8.7665 million yuan, respectively [2]

证券代码：000615 证券简称：*ST美谷 公告编号：2025-082 奥园美谷科技股份有限公司 关于预重整事项进展暨召开第一次临时债权人会议的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有 虚假记载、误导性陈述或重大遗漏。 重要风险提示： 1.公司已进入预重整程序，公司能否进入重整程序尚存在不确定性。 预重整程序是为了提前启动公司债权债务梳理等相关工作，提高后续重整 工作推进效率及重整可行性的程序。襄阳中院同意公司预重整，不代表法院正 式受理申请人对公司的重整申请，截至本公告披露日，公司尚未收到法院关于 受理重整申请的相关法律文书，即申请人的重整申请能否被法院受理、公司后 续能否进入重整程序均存在不确定性。敬请广大投资者注意投资风险。 重整或预重整是否成功也存在不确定性。法院决定受理预重整申请，也不 代表公司正式进入重整程序。如果公司预重整成功，法院将依法审查是否受理 重整申请，公司能否进入重整程序尚存在不确定性。敬请广大投资者注意投资 风险。 2.法院受理重整申请后，公司股票交易存在被实施退市风险警示的风险。 根据《深圳证券交易所股票上市规则（2025 年修订）》（以下简称《股票 ...

奥园美谷科技股份有限公司 预重整方案 二〇二五年十月 | | | | 十一、其他事项 34 | | --- | 释 义 除非本预重整方案中另有明确所指，下列词语的含义为： | 简称 | | 词语含义或全称 | | --- | --- | --- | | 奥园美谷/债务人/ | 指 | 奥园美谷科技股份有限公司 | | 公司 | | | | 襄阳中院 | 指 | 襄阳市中级人民法院 | | 临时管理人 | 指 | 由襄阳中院指定的奥园美谷科技股份有限公司临时 | | | | 管理人 | | 管理人 | 指 | 在襄阳中院裁定受理广州律建对奥园美谷的重整申 | | | | 请后，所指定的奥园美谷科技股份有限公司管理人 | | 奥园科星/控股股 | 指 | 深圳奥园科星投资有限公司 | | 东 | | | | 中国奥园 | 指 | 中国奥园集团股份有限公司 | | 京汉控股/前任控 | 指 | 京汉控股集团有限公司 | | 股股东 | | | | 前任控股股东及 | 指 | 前任控股股东京汉控股及其一致行动人北京合力万 | | 其一致行动人 | | 通信息咨询中心（有限合伙）、段亚娟 | | 广州律建 | 指 | ...

Market Overview - The medical beauty sector experienced a decline of 0.5% on October 10, with Jinbo Biological leading the drop [1] - The Shanghai Composite Index closed at 3897.03, down 0.94%, while the Shenzhen Component Index closed at 13355.42, down 2.7% [1] Stock Performance - The following stocks in the medical beauty sector showed varying performance: - *ST Meigu (000615)*: Closed at 3.30, down 0.30% with a trading volume of 64,200 shares [1] - Aimeike (300896): Closed at 179.84, down 0.32% with a trading volume of 27,000 shares [1] - Huaxi Biological (688363): Closed at 55.78, down 0.76% with a trading volume of 38,500 shares [1] - Jinbo Biological (920982): Closed at 267.48, down 1.95% with a trading volume of 9,733 shares [1] Capital Flow - The medical beauty sector saw a net inflow of 14.16 million yuan from main funds, while retail funds experienced a net outflow of 8.85 million yuan [1] - Detailed capital flow for specific stocks includes: - Aimeike (300896): Net outflow of 11.73 million yuan, down 2.40% [2] - *ST Meigu (000615)*: Net outflow of 1.17 million yuan, down 5.51% [2] - Huaxi Biological (688363): Net outflow of 3.72 million yuan, down 1.72% [2]

Core Viewpoint - *ST Meigu's subsidiary, Jinhua Green Fiber, failed to repay approximately 212 million yuan in debt, leading to the judicial auction of real estate assets by Jinghan Real Estate Group [1][2] Group 1: Legal and Financial Developments - On October 9, *ST Meigu announced significant litigation progress regarding its subsidiary Jinhua Green Fiber's failure to repay debt [1] - The debt originated from a fixed asset loan agreement signed in January 2020, with a repayment plan adjusted in March 2023 [1] - The Xiangyang Intermediate People's Court issued an execution notice demanding Jinhua Green Fiber repay a principal amount of 187,507,905.75 yuan, along with interest and penalties totaling approximately 27.14 million yuan by March 7, 2025 [1] Group 2: Auction Details - The real estate assets of Jinghan Real Estate will be auctioned on October 26, 2025, with a starting price of 154,380,000 yuan [2] - The auction results are uncertain, and if Jinghan Real Estate assumes the guarantee responsibility, it may reduce the liability amounts for other guarantors [2] - *ST Meigu will continue to monitor the litigation progress and disclose updates accordingly [2]

证券代码：000615 证券简称：*ST美谷 公告编号：2025-081 奥园美谷科技股份有限公司 关于重大诉讼进展的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 特别提示： 1、案件所处的诉讼阶段：执行； 2、上市公司所处的当事人地位：被告（担保方）； 3、对上市公司损益产生的影响：本次诉讼对公司本期利润或期后利润的具 体影响需结合实际执行等情况而确定，会计处理及财务数据以审计机构年度审计 确认的结果为准。敬请广大投资者注意投资风险。 一、本次诉讼的基本情况 2020 年 1 月，奥园美谷科技股份有限公司（以下简称"奥园美谷"、"公 司"）控股子公司湖北金环绿色纤维有限公司（以下简称"金环绿纤"）与中国 银行股份有限公司襄阳分行（以下简称"中行襄阳分行"）签订了《固定资产借 款合同》，同时中行襄阳分行分别与京汉置业集团有限责任公司（以下简称"京 汉置业"）、金环绿纤签订《抵押合同》，京汉置业、金环绿纤为前述《固定资 产借款合同》及其修订或补充协议提供抵押担保。公司及其控股子公司湖北金环 新材料科技股份有限公司（以下简称"金环新材料"）、田汉、李莉分别 ...

Core Insights - The medical beauty sector experienced a slight increase of 0.18% on October 9, with Huaxi Biological leading the gains [1] - The Shanghai Composite Index closed at 3933.97, up 1.32%, while the Shenzhen Component Index closed at 13725.56, up 1.47% [1] Medical Beauty Sector Performance - Huaxi Biological (688363) closed at 56.21, with a rise of 1.43% and a trading volume of 40,100 shares [1] - Aimeike (300896) closed at 180.42, down 0.62% with a trading volume of 29,300 shares [1] - ST Meigu (000615) closed at 3.31, down 0.90% with a trading volume of 124,000 shares [1] - Jinbo Biological (920982) closed at 272.80, down 3.12% with a trading volume of 10,000 shares [1] Capital Flow Analysis - The medical beauty sector saw a net outflow of 44.2015 million yuan from main funds and a net outflow of 32.526 million yuan from speculative funds, while retail investors had a net inflow of 76.7274 million yuan [1] - Huaxi Biological had a main fund net inflow of 5.4613 million yuan, accounting for 2.45% of its total [2] - Aimeike experienced a significant main fund net outflow of 47.1115 million yuan, representing 8.95% of its total [2] - ST Meigu had a main fund net outflow of 2.5512 million yuan, accounting for -6.23% of its total [2]